| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afcfc7af43784847a2171ad49795c3c3 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2016-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1450bc5476bd42274b7decb3c6bc50c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2acc3cf98d6f3107c03047ee8a728644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40ee0e93e2ed36b05d21ab7de3759b82 |
| publicationDate |
2018-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2018070563-A |
| titleOfInvention |
Anticancer effect enhancer and cancer treatment support method |
| abstract |
An anti-cancer effect enhancer that enhances the growth inhibitory effect on cancer cells possessed by an anti-cancer agent, and a cancer treatment support method for determining the effect of a combination of the anti-cancer effect enhancer and an anti-cancer agent. A polynucleotide encoding interferon λ4 that enhances anticancer activity in combination with an anticancer agent that is 5-fluorouracil or cisplatin; interferon λ4; or an anti-cancer effect enhancement comprising an agonist for a receptor having interferon λ4 as a ligand Agent. [Selection figure] None |
| priorityDate |
2016-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |